PL407730A1 - Method for obtaining modified montmorillonite - Google Patents
Method for obtaining modified montmorilloniteInfo
- Publication number
- PL407730A1 PL407730A1 PL407730A PL40773014A PL407730A1 PL 407730 A1 PL407730 A1 PL 407730A1 PL 407730 A PL407730 A PL 407730A PL 40773014 A PL40773014 A PL 40773014A PL 407730 A1 PL407730 A1 PL 407730A1
- Authority
- PL
- Poland
- Prior art keywords
- alkyl
- montmorillonite
- carbon atoms
- organic solvent
- chain length
- Prior art date
Links
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical class O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 title abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000002636 imidazolinyl group Chemical group 0.000 abstract 2
- 229910052901 montmorillonite Inorganic materials 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 1
- -1 ion chloride Chemical class 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
Landscapes
- Silicates, Zeolites, And Molecular Sieves (AREA)
Abstract
Sposób otrzymywania modyfikowanego montmorylonitu polega na tym, że montmorylonit dysperguje się w wodzie i/lub w rozpuszczalniku organicznym i miesza się z solami z grupy imidazolin, należącymi do halogenków 1-[n-(alkilokarbamoilo) alkilo]-1-alkilo-2-alkiloimidazoliowych, podstawionymi łańcuchami alkilowymi naturalnych kwasów tłuszczowych o długości łańcucha od 10 do 22 atomów węgla, o wzorze ogólnym 1: gdzie: R1 = łańcuch alkilowy o długości od 10 do 22 atomów węgla, R2 = grupa benzylowa, metylowa lub wodór, X- = jon chlorkowy, bramkowy lub jodkowy, n = 1-10, rozpuszczonymi w wodzie i/lub w rozpuszczalniku organicznym, stosując 10-150 mmoli soli z grupy imidazolin na 100 g montmorylonitu, w temperaturze 50-100°C i w czasie nie krótszym niż 30 minut, roztwór przesącza się, uzyskany osad suszy się i ewentualnie mieli się do postaci proszku.The method of obtaining the modified montmorillonite is that the montmorillonite is dispersed in water and/or in an organic solvent and mixed with salts from the imidazoline group, belonging to the 1-[n-(alkylcarbamoyl)alkyl]-1-alkyl-2-alkylimidazolium halides , substituted with alkyl chains of natural fatty acids with a chain length of 10 to 22 carbon atoms, of general formula 1: where: R1 = alkyl chain length of 10 to 22 carbon atoms, R2 = benzyl, methyl or hydrogen group, X- = ion chloride, gated or iodide, n = 1-10, dissolved in water and/or in an organic solvent, using 10-150 mmol of a salt of the imidazoline group per 100 g of montmorillonite, at a temperature of 50-100 °C for not less than 30 minutes , the solution is filtered, the resulting precipitate is dried and optionally ground to a powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL407730A PL228361B1 (en) | 2014-03-31 | 2014-03-31 | Method for obtaining modified montmorillonite |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL407730A PL228361B1 (en) | 2014-03-31 | 2014-03-31 | Method for obtaining modified montmorillonite |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL407730A1 true PL407730A1 (en) | 2015-10-12 |
| PL228361B1 PL228361B1 (en) | 2018-03-30 |
Family
ID=54266736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL407730A PL228361B1 (en) | 2014-03-31 | 2014-03-31 | Method for obtaining modified montmorillonite |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL228361B1 (en) |
-
2014
- 2014-03-31 PL PL407730A patent/PL228361B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL228361B1 (en) | 2018-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201501122A8 (en) | NEW AGONISTS OF SOMATOSTATIN RECEPTORS OF SUB-TYPE 4 (SSTR4) | |
| CY1125963T1 (en) | P2X3 AND P2X2/3 DIAMINOPYRIMIDINE RECEPTOR REGULATORS FOR USE IN COUGH TREATMENT | |
| CY1124537T1 (en) | PYRIDONE DERIVATIVE HAVING A TETRAHYDROPYRANYL METHYL GROUP | |
| CY1119473T1 (en) | 1-HYDROXY-BENZOXAVOROLA AS ANTI-PARASITIC FACTORS | |
| AR081060A1 (en) | PROCEDURE TO PREPARE 4- {4 - [({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] AMINO} CARBONYL) AMINO] -3-FLUOROPHENOXY} -N-METHYLPIRIDIN-2-CARBOXAMIDE | |
| PH12016502334B1 (en) | Method for producing fused heterocyclic compound | |
| TN2017000204A1 (en) | Triazolopyrimidine compounds and uses thereof | |
| NZ629025A (en) | Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists | |
| EA201790407A1 (en) | PROBES FOR VISUALIZATION PROTEIN HANTINGTIN | |
| UA122781C2 (en) | PESTICIDELY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR-CONTAINING SUBSTITUENTS | |
| PE20171511A1 (en) | PIPERIDINE UREA 4-METHYLSULFONYL-SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF DILATED MYOCARDIOPATIA (DCM) | |
| MX351812B (en) | Pyridone derivative. | |
| AR098110A1 (en) | PROCESS FOR THE PREPARATION OF 3- (3-CHLORINE-1H-PIRAZOL-1-IL) PIRIDINE | |
| MX2017003999A (en) | Boronic acid derivatives. | |
| CY1120515T1 (en) | CYCLOYLIC ACID PRODUCER, METHOD OF PREPARATION AND PHARMACEUTICAL APPLICATION | |
| MX2016008910A (en) | Phenyl-triazolo-pyridine compounds. | |
| EA201690515A1 (en) | DERIVATIVES OF DIAZOCARBAZOLE AS PET-LIGANDS PROTEIN TAU | |
| BR112017006420A2 (en) | boronic acid derivatives | |
| MX377235B (en) | IMPROVED PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES. | |
| EA201591349A1 (en) | METHOD OF OBTAINING VORTIOXETIN | |
| MY195528A (en) | 5-Ethyl-4-Methyl-Pyrazole-3-Carboxamide Derivative Having Activity as Agonist of Taar | |
| EA201790400A1 (en) | PROBES FOR VISUALIZATION PROTEIN HANTINGTIN | |
| MY190283A (en) | Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation | |
| BR112015028740A2 (en) | process for preparing 1,4: 3,6-dianhydroxytol dicarbamates, precursor chemical compound, chemical compound derived from at least one of the precursor chemical compounds, and method of preparing a chemical compound derived from at least one of the precursor chemical compounds | |
| EP3769757A3 (en) | Imaging histone deacetylases with a radiotracer using positron emission tomography |